Skip to content

Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering

EXPérimentation d'Envoi Postal DIrect à Domicile du kiT de dépistage du Cancer Colorectal Sans Commande préalable [Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06032338
Acronym
EXPEDIT
Enrollment
64000
Registered
2023-09-13
Start date
2023-09-14
Completion date
2026-11-14
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Screening, Participation

Brief summary

The effect of mailing FIT with the invitation on participation and colonoscopy rates will be evaluated in a randomized controlled trial conducted in the Centre-Val de Loire (CVL) region, involving 64,000 people from the population eligible for colorectal cancer population-based organised screening program (CRC-PBOSP). In the "C" control group, invitations, test delivery and reminders will be carried out in accordance with the CRC-PBOSP rules at the time of the study. Intervention group "B" will evaluate two experimental modes of invitation with direct home mailing of the test: * Method "B1": invitation with test sent to home without prior information letter * Method "B2": information letter followed by invitation with test sent home, designed to optimize participation by first-time subjects (aged 50-51) invited to the CRC-PBOSP for the first time. Ancillary studies will focus 1/ on acceptability of this intervention (qualitative study on a few general practitioners, gastroenterologists and invitees), 2/ on social and geographical inequalities of participation on a subsample of individuals included in EXPEDIT study using ecological indices (EDI, SCALE).

Interventions

OTHERCRC screening invitation not including the screening test.

The invitation to CRC-PBOSP will only contain informations on how to get the screening test.

OTHERMailing of FIT with invitation

The invitation to CRC-PBOSP will contain the CRC screening test.

OTHERInformation letter before invitation

An information letter will be sent to future invitees a few weeks before the invitation, to announce the mailing of the CRC screening kit.

Sponsors

University Hospital, Caen
Lead SponsorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
Centre Régional de Coordination des Dépistages des Cancers (CRCDC) Centre Val de Loire
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

The number of study arms will differ according to age-group: * In 50 or 51 yrs age-group, individuals (n=5760 ) will be randomised in 3 groups: C, B1 and B2 (allocation ratio 2:1:1) * In the age-group older than 51 yrs, individuals (n=58240) will be randomised in 2 groups: C, and B1 (allocation 1:1) In the main analysis including both age-groups, B1 and B2 arms would be pooled.

Eligibility

Sex/Gender
ALL
Age
50 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* 50 to 74 years old * Resident of Centre Val de Loire French area * Eligible for CRC screening invitation within the biennal CRC-PBOSP during the inclusion period * Affiliated to the health insurance scheme

Exclusion criteria

* CRC screening

Design outcomes

Primary

MeasureTime frameDescription
Performance of colonoscopy in FIT positive patients6 months after the positive FITRate of Colonoscopy within 6 months after positive FIT among invitees with a positive FIT
Participation to CRC screening program16 months after the invitationRate of FIT sent to laboratory for analysis within 16 of months of invitation among invitees.

Secondary

MeasureTime frameDescription
Participation to CRC screening program at 24 months24 months after invitationRate of FIT sent to laboratory for analysis within 24 of months of invitation among invitees.
Time to screening participation24 months after invitationTime to screening participation within 24 months of invitation among invitees
Colonoscopy in FIT positive patients, 12 months after the positive test12 months after the positive testRate of Colonoscopy within 12 months after positive FIT among invitees with a positive FIT
Time to colonoscopy (in FIT positive patients)12 months after the positive testTime from FIT to colonoscopy within 12 months of positive FIT among invitees with a positive FIT
Cost-effectiveness analysis24 monthsCosts of CSC-PBOSP from invitation to colonoscopy when necessary
Colonoscopy findings12 months after the positive testRate of colorectal cancer or advanced neaplasia in invitees with a positive FIT
Participation to CRC screening program in first invitees (50-51 yrs-old)16 months after invitationRate of FIT sent to laboratory for analysis within 16 of months of invitation among first invitees (50-51 yrs-old)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026